越南河内老年人认知障碍的决定因素:蒙特利尔认知评估的见解
Doan Thi Hue1,2, Le Thi Thu Ha1,2, Nguyen Van Tuan1,2
1Department of Psychiatry, Hanoi Medical University, Hanoi, Vietnam.
Clinical neuropsychiatry
|March 2, 2026
概括
认知障碍影响了河内70%以上的老年人,年龄和身体不活动是关键的危险因素. 解决生活方式和社会经济因素对于促进越南健康的认知衰老至关重要.
科学领域:
- 老年学与公共卫生
- 神经科学和衰老研究研究
- 认知衰退的流行病学
背景情况:
- 认知障碍在全球范围内构成了重大公共卫生挑战,特别是在老年人群中.
- 关于越南认知障碍的患病率和决定因素的证据有限.
- 了解这些因素对于制定有针对性的干预措施至关重要.
研究的目的:
- 为了确定越南河内老年人中认知障碍的患病率.
- 识别与认知障碍相关的人口,社会经济,生活方式和健康相关因素.
- 为该地区的认知衰老公共卫生战略提供信息.
主要方法:
- 这是一项涉及河内60岁及以上的763名成年人的横截面研究.
- 使用蒙特利尔认知评估 (MoCA) 评估的认知功能.
- 多变量逻辑回归用于识别认知障碍的独立预测因素,控制心理健康,焦虑和睡眠质量.
主要成果:
- 认知障碍的高患病率 (70.4%),其中46.1%轻度,19.3%中度,5.0%重度.
- 年龄是最强的预测因素 (OR=1.11每年).
- 显著的风险因素包括女性性别,低学历,农村居住,缺乏养老金收入,身体不活动 (最大效果大小,OR=3.18),睡眠质量差以及心理健康障碍.
结论:
- 认知障碍在河内老年人群中非常普遍.
- 人口,社会经济和可修改的健康因素显著影响认知健康.
- 促进身体活动,心理健康,经济安全和可访问的老年护理的干预措施对于越南的健康认知衰老至关重要.
相关概念视频
01:30Cognitive Development During Adulthood
999
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
999
01:30Dementia
614
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
614
01:26Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
751
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
751